Fabentech

Fabentech is a French biopharmaceutical company and one of the leading European developers and manufacturers of emergency therapeutics to address high priority biological threats. We support nations in building resilience by the stockpiling of medical countermeasures to respond to future pandemics and bioterror risks. Backed by trusted partnerships with defense and health authorities, we are bringing to market the world’s first antidote to treat ricin intoxication.
Fabentech is an integrated company, combining research, development, manufacturing, and deployment capabilities. Our antibody-based platform is a robust and validated technology capable of targeting multiple biological agents, enabling reliable supply for preparedness and health security efforts worldwide.